101
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Chromium picolinate supplementation improves cardiac performance in hypoxic rats

ORCID Icon
Pages 387-397 | Received 12 Feb 2021, Accepted 09 Feb 2022, Published online: 31 Aug 2022

References

  • Milano G, Bianciardi P, Rochemont V, et al. Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium. PLoS One. 2011;6(11):e27910.
  • Fan C, Iacobas DA, Zhou D, et al. Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia. Physiol Genomics. 2005;22(3):292–307.
  • Kimoff RJ, Brooks D, Horner RL, et al. Ventilatory and arousal responses to hypoxia and hypercapnia in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med. 1997;156(3 Pt 1):886–894.
  • Angerio AD, Lee ND. Sickle cell crisis and endothelin antagonists. Crit Care Nurs Q. 2003;26(3):225–229.
  • Gozal D, Reeves SR, Row BW, et al. Respiratory effects of gestational intermittent hypoxia in the developing rat. Am J Respir Crit Care Med. 2003;167(11):1540–1547.
  • Bass JL, Corwin M, Gozal D, et al. The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics. 2004;114(3):805–816.
  • Park AM, Suzuki YJ. Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. J Appl Physiol (1985). 2007;102(5):1806–1814.
  • Jain V. Clinical perspective of obstructive sleep apnea-induced cardiovascular complications. Antioxid Redox Signal. 2007;9(6):701–710.
  • Schweitzer P. Cardiac arrhythmias in obstructive sleep apnea. Vnitr Lek. 2008;54(10):1006–1009.
  • Serebrovskaya TV, Manukhina EB, Smith ML, et al. Intermittent hypoxia: cause of or therapy for systemic hypertension? Exp Biol Med (Maywood). 2008;233(6):627–650.
  • Brisco MA, Goldberg LR. Sleep apnea in congestive heart failure. Curr Heart Fail Rep. 2010;7(4):175–184.
  • Dong JW, Zhu HF, Zhu WZ, et al. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res. 2003;13(5):385–391.
  • Ding HL, Zhu HF, Dong JW, et al. Intermittent hypoxia protects the rat heart against ischemia/reperfusion injury by activating protein kinase C. Life Sci. 2004;75(21):2587–2603.
  • Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, et al. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol (1985). 2005;98(5):1691–1696.
  • Tang H, Xiao Q, Xu H, et al. Hypoglycemic activity and acute oral toxicity of chromium methionine complexes in mice. J Trace Elem Med Biol. 2015;29:136–144.
  • Staniek H, Krejpcio Z. The effects of supplementary Cr3 (Chromium(III) Propionate Complex) on the mineral status in healthy female rats. Biol Trace Elem Res. 2017;180(1):90–99.
  • Vincent JB. Is the pharmacological mode of action of Chromium(III) as a second messenger? Biol Trace Elem Res. 2015;166(1):7–12.
  • Landman GWD, Bilo HJG, Houweling ST, et al. Chromium does not belong in the diabetes treatment arsenal: Current evidence and future perspectives. World J Diabetes. 2014;5(2):160–164.
  • Willoughby D, Hewlings S, Kalman D. Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review. Nutrients. 2018;10(12):1876.
  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on dietary reference values for chromium: dietary reference values for chromium. EFSA J. 2014;12:3845.
  • Vincent JB. New evidence against chromium as an essential trace element. J Nutr. 2017;147(12):2212–2219.
  • Casalegno C, Schifanella O, Zennaro E, et al. Collate literature data on toxicity of Chromium (Cr) and Nickel (Ni) in experimental animals and humans. EFSA Supporting Publications. 2015;12: EN-478.
  • Sundaram B, Aggarwal A, Sandhir R. Chromium picolinate attenuates hyperglycemia-induced oxidative stress in streptozotocin-induced diabetic rats. J Trace Elem Med Biol. 2013;27(2):117–121.
  • Sushko OO, Iskra RJ, Ponkalo LI. Influence of chromium citrate on oxidative stress in the tissues of muscle and kidney of rats with experimentally induced diabetes. Regul Mech Biosyst. 2019;10(2):209–214.
  • Qi SS, Zheng HZ, Jiang H, et al. Protective effects of chromium picolinate against diabetic-induced renal dysfunction and renal fibrosis in streptozotocin-induced diabetic rats. Biomolecules. 2020;10(3):398.
  • Kooshki F, Tutunchi H, Vajdi M, et al. A comprehensive insight into the effect of chromium supplementation on oxidative stress indices in diabetes mellitus: a systematic review. Clin Exp Pharmacol Physiol. 2021;48(3):291–309.
  • Refaat MRA, El-Karemi MMA, Diab FMA. Abdel-Hady EA. Studies on the effects of chromium supplementation on the metabolic responses to exercise. Ain Shams Med J. 2005;56:447–467.
  • Bucher M, Sandner P, Wolf K, et al. Cobalt but not hypoxia stimulates PDGF gene expression in rats. Am J Physiol. 1996;271(3 Pt 1):E451–457.
  • Chen L, Einbinder E, Zhang Q, et al. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med. 2005;172(7):915–920.
  • Goldschlager N, Wagner G. Electrocardiography: essentials of interpretation. Middle East Edition. Los Angeles (CA): Lang Medical Publications; 1984.
  • Langendorff O. Untersuchungen am ü berlebenden Säugetierherzen. Pflügers Arch. 1895;61(6):291–332.
  • Ayobe MH, Tarazi RC. Beta-Receptors and contractile reserve in left ventricular hypertrophy. Hypertension. 1983;5(2 Pt 2):I192–197.
  • Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–358.
  • Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126.
  • Zoccal DB, Bonagamba LG, Oliveira FR, et al. Increased sympathetic activity in rats submitted to chronic intermittent hypoxia. Exp Physiol. 2007;92(1):79–85.
  • Ramond A, Godin-Ribuot D, Ribuot C, et al. Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia. Fundam Clin Pharmacol. 2013;27(3):252–261.
  • Stritzke J, Mayer B, Lieb W, et al. Haematocrit levels and left ventricular geometry: results of the MONICA Augsburg Echocardiographic Substudy. J Hypertens. 2007;25(6):1301–1309.
  • Rochette L, Moreau D, Opie LH. Effect of repeated regional myocardial ischemia in the rat heart on reperfusion arrhythmias and release of norepinephrine. J Cardiovasc Pharmacol. 2001;38(1):78–89.
  • Dzeja PP, Redfield MM, Burnett JC, et al. Failing energetics in failing hearts. Curr Cardiol Rep. 2000;2(3):212–217.
  • Lalande S, Johnson BD. Diastolic dysfunction: a link between hypertension and heart failure. Drugs Today (Barc). 2008;44(7):503–513.
  • Netticadan T, Temsah R, Osada M, et al. Status of Ca2+/calmodulin protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion. Am J Physiol. 1999;277(3):C384–391.
  • Abdel-Hady EA, Ahmed MA, EL-Salamony GI, et al. Cardiovascular dysfunction in experimental diabetes: effect of treatment with insulin and chromium. Sci Med J. 2008;20:31–48.
  • Proctor SD, Kelly SE, Stanhope KL, et al. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diabetes Obes Metab. 2007;9(1):87–95.
  • Preuss HG, Grojec PL, Lieberman S, et al. Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol. 1997;47(5):325–330.
  • Dong F, Yang X, Sreejayan N, et al. Chromium (D-phenylalanine)3 improves obesity-induced cardiac contractile defect in ob/ob mice. Obesity (Silver Spring). 2007;15(11):2699–2711.
  • Abebe W, Liu JY, Wimborne H, et al. Effects of chromium picolinate on vascular reactivity and cardiac ischemia-reperfusion injury in spontaneously hypertensive rats. Pharmacol Rep. 2010;62(4):674–682.
  • Chen L-L, Yin H, Huang J. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis. Cardiovasc Pathol. 2007;16(4):221–230.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.